Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to assess the therapeutic activity of idarubicin as
salvage treatment in patients with recurrent or progressive lymphoma in the central nervous
system.
Phase:
Phase 2
Details
Lead Sponsor:
International Extranodal Lymphoma Study Group (IELSG)